On June 13, WellDoc announced the upcoming launch of BlueStar , an FDA-approved software-based product that is prescribed by a HCP to support the management of type 2...

The technology giant, Google recently announced that it is working to develop a contact lens that could non-invasively monitor glucose levels from tears. The smart...

On February 19, Abbott announced a recall of FreeStyle and FreeStyle Flash blood glucose meters, which may produce low blood sugar results incorrectly when used with...

On December 2, the influential Helmsley Charitable Trust (HCT), one of the world’s largest funders of type 1 diabetes research – and the 12th largest private foundation...

Newly diagnosed with type 1 diabetes? The top ten things you should know!

At ADA this year, type 2 drugs for type 1 diabetes show lots of promise. Plus, the latest exciting data on the Medtronic Veo and hypoglycemia.

LifeScan’s OneTouch VerioSync meter – the magic of wireless blood glucose data to your iPhone/iPod/iPad.

On November 18, the University of Virginia (UVA) announced that it received a $3.4 million NIH grant for three artificial pancreas studies to be conducted at UVA and...

Medtronic MiniMed 530G and Enlite CGM – Opening the Door to Closing the Loop.

We ask ACA expert Dr. Jack Lord all the hard questions on healthcare coverage and reimbursement.

Dr. Damiano reveals the much anticipated data from the bionic pancreas trials at the biggest diabetes tech conference of the year.

My Diabetes Home is an online dashboard that allows patients to record, organize, and track personal diabetes information, including medications, daily blood sugars, A1c...

All you need to know about diabetic neuropathy - the facts, prevention, and treatment.

The “Bionic Kids” put the artificial pancreas through the rigors of summer camp.

Top 10 Things I Wish My Parents Knew When I Was Diagnosed with Type 1 Diabetes.

The top three things I’d like to see in 2014 – updates on CGM, mHealth, and combination therapy.

On March 25, Tandem Diabetes launched t:connect, its web-based diabetes management application (PC and Mac!) that downloads data from the t:slim insulin pump and seven...

MannKind’s inhalable ultra-rapid-acting insulin Afrezza has its day at the FDA – find out what it can do for patients and how to speak up!

Choosing an insulin pump that will best meet YOUR needs.

The New York Times publishes a critical front page piece on type 1 diabetes costs and devices - what we wish they would have written.